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to FDG-PET, the voxel values were averaged and used as 
tentative FDG N-values. (5) The threshold of FDG-PET 
and whether to use the mode or the mean voxel values 
were computationally optimized using learning data sets. 
(6) Applying the optimal threshold and either the mode or 
mean, N-values of FDG and MET were finally determined.
Results N-values determined by our automated method 
showed excellent agreement with those determined by 
a manual ROI method (ICC(2,1) > 0.78). These values 
were significantly correlated with mean manual N-values 
(p < 0.001).
Conclusions Our new method shows sufficiently good 
agreement with the standard method and can provide a 
more objective metabolic index.
Keywords Brain tumour · Voxel-based analysis · FDG-
PET · MET-PET · Tumour-to-normal ratio
Introduction
The combination of 18F-fluorodeoxyglucoe (FDG) and 
11C-methionine (MET) has been the most effective PET 
examination for evaluating brain tumours [1–4]. FDG 
uptake increases with the degree of malignancy in com-
mon brain tumour types [1, 4–7]. However, an uptake of 
FDG is also seen in the normal cortex, which compli-
cates tumour delineation. In addition, FDG uptake in the 
normal cortex is altered depending on neuronal activi-
ties, which can be affected by various factors, such as 
subclinical epileptic discharge, tumour invasion, and 
tissue damage from past treatment. These factors should 
be considered when identifying the reference area in 
the normal cortex. MET-PET overcomes these difficul-
ties, because MET distribution in the normal cortex is 
Abstract 
Objective The tumour-to-normal ratio (T/N) is a rep-
resentative index reflecting brain tumour activity by 
18F-fluorodeoxyglucose (FDG) and 11C-methionine (MET) 
PET. We proposed a new automated method of calculating 
the normal reference value (N-value) for use as the denom-
ination of T/N. This method uses voxel-based analysis of 
FDG- and MET-PET images. We compared the results of 
this method with those of the standard region-of-interest 
(ROI) method.
Methods Data sets were obtained from 32 patients with 
newly diagnosed glioma and 13 patients with recurrent 
brain tumour. Our methods were as follows: (1) FDG-PET 
and MET-PET images were co-registered. (2) The areas 
where the FDG uptake was higher than a set threshold were 
selected. (3) For the corresponding areas of MET-PET 
images, mode and mean voxel values were calculated as 
tentative MET N-values. (4) Applying the same coordinates 
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very low and usually not affected by changes in neuronal 
activity [8]. Therefore, FDG-PET and MET-PET work 
in a complementary manner to effectively evaluate brain 
tumours.
When evaluating tumour metabolism, a visual inspec-
tion by nuclear medicine experts is usually sufficient for 
the diagnosis of tumour malignancy; however, the dis-
crimination of uptake level is limited by it being a quali-
tative process. Therefore, visual inspection is insufficient 
as a basis for deciding a new drug’s efficacy or for deter-
mining a cut-off value for use in treatment management 
of patients with similar conditions. Therefore, a more 
objective measurement method is needed.
Metabolic indices, such as standardized uptake value 
(SUV), tumour-to-normal ratio (T/N), and their modi-
fications, have been used in the previous studies [1, 3, 
9–11]. Among these indices, the T/N ratio is the most 
frequently used and is more favourable for the evalua-
tion of tumour aggressiveness, which also means that 
the normal cortex is the most appropriate region to use 
as a reference when evaluating tumour uptake [1, 9]. 
Compared with T/N ratio, SUV is more prone to inter-
subject variability for factors, such as body composition, 
given that SUV represents the ratio of tumour activity 
to average body concentration, which is calculated from 
injected FDG activity and body weight [12].
The T/N ratio is calculated by dividing the tumour 
SUV by a reference SUV obtained from the normal cor-
tex. Usually, regions-of-interest (ROIs) are placed on the 
hottest area of the tumour and on an area that appears to 
be the normal cortex to determine the tumour value and 
the normal value, respectively. Although the hottest area 
of the tumour is uniquely determined in most cases, the 
normal cortex area may not always be reliably identified 
by visual inspection because of various factors that affect 
neuronal activity. This is especially true when determin-
ing the normal cortex area from FDG-PET images.
In this study, we propose a new automated method in 
which the voxels corresponding to the normal cortex are 
identified using characteristics of both FDG-PET and 
MET-PET, and in which the normal reference values 
(N-values) are calculated through voxel-based analysis. 
This method was developed assuming that FDG uptake 
is relatively high in the normal brain cortex, and that 
the tumour extent on MET-PET does not exceed more 
than half of the brain cortex area in most clinical set-
tings. The combination of these characteristics allows 
the identification of the voxels corresponding to the 
normal cortex in both of FDG and MET-PET images. If 
this method is validated, it may provide a more objective 
index for clinical use.
Materials and methods
Patients
We identified 45 patients who underwent both FDG-PET 
and MET-PET for the evaluation of brain tumour in our 
department between Mar 2009 and Sep 2014. The patho-
logical diagnosis was performed according to the 2007 
World Health Organization guidelines. Thirty-two of these 
45 patients (21 men, 11 women; mean age 48 ± 15 years) 
had untreated primary glioma: 11 with glioblastoma; 12 
with anaplastic glioma (8 astrocytoma, 3 oligodendro-
glioma, and 1 oligoastrocytoma); and 1 with pilocytic astro-
cytoma. Thirteen of these 45 patients (9 men, 4 women; 
mean age 54 ± 14 years) experienced recurrence of brain 
tumour after surgery: 5 with anaplastic glioma (2 astrocy-
toma, 2 oligodendroglioma, and 1 central neurocytoma); 1 
with lung cancer metastasis; and 2 with anaplastic menin-
gioma. We divided the patients into three groups. Group 1 
consisted of 20 patients who were randomly selected from 
the patients with untreated primary glioma, group 2 con-
sisted of the remaining 12 untreated patients, and group 3 
consisted of all 13 patients with recurrent brain tumour. 
The data obtained from group 1 were used as the learning 
data set of the automated method. The data obtained from 
groups 2 and 3 were used for the validation of this method. 
Written informed consent was obtained from all patients. 
This retrospective study was approved by the institutional 
review board at our hospital.
PET/CT protocol
The patients fasted for at least 5 h prior to FDG-PET imag-
ing. The patients rested in the supine position with an eye 
mask in a quiet PET room to minimize the confounding 
factors of environmental noises. A 296-MBq (8 mCi) dose 
of FDG was injected intravenously, and emission scans 
were obtained 45 min later in three-dimensional mode for 
10 min using a PET/CT scanner (Aquiduo, Toshiba Medi-
cal System, Otawara, Japan). Photon attenuation correction 
was performed using a low-dose CT scan. The PET scan-
ner contained 24,336 lutetium oxyorthosilicate crystals in 
39 detector rings and had an axial field of view of 16.2 cm, 
and 82 transverse slices of 2.0-mm thickness. The intrinsic 
full width at half-maximum (FWHM) spatial resolution at 
the centre of the field of view was 4.3 mm, and the FWHM 
axial resolution was 4.7  mm. PET images were recon-
structed using Fourier rebinning ordered subset expectation 
maximization iterative reconstruction, with 2 iterations and 
8 subsets, and a 4-mm FWHM Gaussian filter was applied. 
The data were collected in a 128 × 128 × 41 matrix with a 
voxel size of 2.0 × 2.0 × 4.0 mm.
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For MET-PET imaging, a 740-MBq (20  mCi) dose of 
MET was injected intravenously, and a 10-min emission 
scan was started 30  min after the injection. The PET/CT 
scanner and image reconstruction protocols were the same 
as the protocols used for FDG-PET imaging.
To conveniently analyse PET images, all voxel values 
from PET images were normalized to SUV using patient 
body weight (g), injected radioactivity (Bq/ml), and a 
cross-calibration factor (Bq/cps), assuming a specific grav-
ity of 1 g/ml.
Manual ROI-based method
Three experienced nuclear medicine physicians partici-
pated as operators in this study. Each of the operators sepa-
rately placed four circular ROIs with 10-mm diameters on 
the axial FDG-PET images and MET-PET images manu-
ally. These were then compared side-by-side. On the basis 
of visual inspection, operators placed ROIs in the hemi-
sphere contralateral to the tumour in areas that appeared 
to be normal grey matter of the superior frontal area and 
the parietal lobe at the centrum semiovale level, as well 
as in the inferior frontal area and the temporal lobe at the 
striatum level. MRI images were also compared with PET 
images as needed. Each of the three operators calculated a 
manual N-value by averaging the four ROI measurements. 
The resulting three N-values were then averaged to produce 
the “mean manual N-value” used in this study.
Automated voxel-based method
We developed an automated voxel-based method to 
determine the N-value for the T/N index. This method 
was programmed using statistical parametric mapping 8 
(SPM8) and MATLAB version R2014a (MathWorks Inc., 
Natick, MA, USA). The method consisted of four image 
processing steps and one optimization step. A flowchart 
of the image processing steps is shown in Fig. 1. In the 
first step, FDG-PET images were intra-subjectively 
co-registered to MET-PET images using a normalized 
mutual information method in SPM8. Co-registration 
was visually verified by ensuring anatomical agreement 
between MET-PET and co-registered FDG-PET using 
the overlay and the crossbar function of MRIcro (http://
www.mricro.com). In the second step, a candidate region 
of normal grey matter was selected from the co-registered 
FDG-PET as one that had a voxel value higher than a 
determined optimal threshold. The optimization method 
for determining this threshold is described below. In the 
third step, mean and mode MET-PET voxel values from 
the previously selected normal grey areas were calculated 
as tentative MET N-values. To calculate mode, histogram 
bin size was set as 0.1 intervals of SUV. Whether to use 
the mean or the mode as the parameter in our method was 
also determined using the optimization method described 
below. Tentative FDG N-values were calculated by aver-
aging the voxel values that corresponded to the same 
area as was used to obtain the tentative MET N-values. 
The most optimal conditions, as determined by the 
Fig. 1  Flowchart of image 
processes for calculating normal 
brain cortex value (N-value). 
For steps 2 and 3, the threshold 
and whether to use “mean” or 
“mode” were determined in the 
optimization step which is not 
shown in this flowchart. The 
goal of this computation method 
is to be able to calculate an 
appropriate N-value
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optimization step, were then applied to obtain the final 
N-values for both MET and FDG.
In the optimization step, we used the data from group 
1 to decide two parameters: the threshold value of FDG-
PET and whether to use the mean or the mode voxel 
values from MET-PET. Tentative N-values from the 
automated voxel-based method were computed by com-
bining either the mean values or the mode values with 
thresholds ranging from 1.0 to 3.0 times the global mean 
of FDG-PET in increments of 0.1. The global mean of 
FDG-PET as calculated after eliminating the voxels out-
side the brain by masking out values that were less than 
or equal to one-eighth of the mean total voxel value of 
the original image. Using these tentative N-values of 
each subject by three operators with manual method and 
those with automated method, intraclass correlation coef-
ficients with a two-way random-effects model (ICC(2,1)) 
were calculated and the optimal parameters were deter-
mined by maximizing ICC value.
Statistical analysis for validation of the automated 
method using groups 2 and 3
Our automated voxel-based method, which used param-
eters determined by an optimization process, was applied 
to the patient imaging data from groups 2 and 3 for vali-
dation. To test the reliability of the 3 operator determined 
manual N-values and the automated N-value, ICC(2,1) 
values were calculated [13]. An ICC ranging from 0.81 
to 0.99 is considered to show a substantial agreement 
[14]. Pearson’s correlation coefficients were calculated 
to ascertain the linear association between the automated 
N-value and the mean manual N-value. In addition, 
paired t-tests were performed to determine the signifi-
cance of the differences between the results of the auto-
mated and manual method, and a Bland–Altman plot was 
used to identify systemic differences. All statistical tests 
were two-tailed, and p < 0.05 was set as the threshold 
for statistical significance. All analyses were performed 
using SPSS 20.0 (IBM, Armonk, NY, USA).
Results
Optimization of the parameters
Using the data from patient group 1, ICC value reached 
the maximum value at a threshold of 2.3 of the FDG-PET 
and the mod values of MET-PET (Fig. 2).
Validation of the automated method
Co-registration of FDG- and MET-PET was successfully 
achieved in all of our patients without the need for manual 
modification.
We checked our method by visually confirming that the 
selected voxels did not include tumour area and included 
only visually determined normal grey matter, which was 
achieved automatically without any human interactions in 
all patients. Representative images of manual ROI place-
ments and those of processes with the automated voxel-
based method are shown in Figs.  3 and 4. An FDG- and 
MET-avid tumour was visualized in the left frontal lobe 
of a patient in group 2 (Fig.  3a, b). Using the automated 
method, the tumour area was successfully excluded 
(Fig. 3c–e). Figure 4 shows images from a patient in group 
3. The FDG uptake in the right hemisphere was decreased 
probably due to a previous surgery and radiation treatment 
(Fig. 4a). A recurrent tumour with a slightly increase MET 
uptake is visible in the posterior area of the resection cavity 
(Fig. 4b). Through the processes of the automated method 
(Fig. 4c–d), the abnormally decreased FDG uptake area and 
the recurrent tumour were successfully excluded (Fig. 4e).
Statistical analysis for validation
Scatter plots of the N-values obtained from the automated 
voxel-based method and those obtained from each of the 
three operators using the manual ROI method are shown 
in Figs.  5 and 6. The automatically calculated N-values 
were within the range of the three N-values determined 
manually in 16/25 (64%) patients for the FDG-PET data, 
and in 15/25 (60%) patients for MET-PET data. Most of 
the N-values that were out of the manual range were very 
Fig. 2  Changes of ICC by threshold value in the optimization step. 
The X-axis shows the threshold values based on the global mean 
of FDG-PET. Mode refers to the most frequent MET voxel value 
and mean refers to the average value of MET voxels within the area 
selected by the threshold method. The ICC is maximum at the thresh-
old 2.3 for the mode curve (arrow)
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close to at least one of the operator N-values. The origi-
nal N-values and resulting T/N values are presented in the 
supplementary files (Online Resource 1). Although tumour 
values were not addressed in this study, they were calcu-
lated by placing one circular ROI with a 10-mm diameter 
on the hottest area of the tumour to demonstrate the differ-
ences in T/N ratio.
The results of ICC(2,1) and the corresponding 95% con-
fidential intervals (95%CI) are shown in Table 1. ICC(2,1) 
of the manual and automated methods was within the range 
of 0.81 to 0.99 for the FDG values of group 2, and FDG 
and MET values of group 3, which, therefore, can be con-
sidered substantial. In the MET of group 2, ICC(2,1) was 
slightly low; however, the value of the manual and auto-
mated methods was not changed from that of ICC(2,1) 
across three operators only.
Scatter plots of the automatically calculated N-values 
and the mean manual N-values are shown in Fig.  7. Sig-
nificant linear correlations were found for both validation 
groups. No significant differences were found using paired 
t-tests.
Bland–Altman plots are shown in Fig. 8. The mean dif-
ferences and limits of agreement (mean, mean-1.96 SD, 
mean + 1.96 SD) are as follows; −0.30, −1.49, +0.90 for 
FDG-PET from group 2 (Fig.  8a), −0.008, −0.19, +0.16 
for MET-PET from group 2 (Fig. 8b), −0.02, −0.79, +0.77 
for FDG-PET from group 3 (Fig.  8c), and −0.02, −0.15, 
+0.11 for MET-PET from group 3 (Fig. 8d). No fixed bias 
was found. Proportional error was found in the values from 
MET-PET group 3 and from FDG-PET groups 2 and 3, 
in which the automated method had a tendency to overes-
timate the N-value for patients with a low-mean manual 
N-value and to underestimate the N-value in patients with 
a high-mean manual N-value. The highest overestimated 
FDG and MET N-values were 116 and 104% of the mean 
manual N-values, respectively. The lowest underestimated 
FDG and MET N-values were 88 and 91% of the mean 
manual N-values, respectively.
Discussion
We report the development of a new automated voxel-based 
method to calculate the N-value required for the T/N index 
used to evaluate brain tumour. Furthermore, we demon-
strate that this method is significantly reliable and that the 
N-values obtained by this new automated method and the 
conventional manual ROI-based method are significantly 
correlated. This new method can be applied regardless of 
whether a patient has undergone surgical treatment. To our 
Fig. 3  Representative images and data from a patient in group 2. a, b 
Four red circles show the ROIs that were placed manually at the cen-
trum semiovale level and at the striatum level on FDG-PET (a) and 
MET-PET (b). A brain tumour with a high uptake of FDG and MET 
is located in the left frontal lobe (arrows). c Representative slice of 
co-registered FDG-PET. The red area shows the candidate region 
for normal grey matter determined using the FDG threshold method, 
but the FDG-avid tumour is still included. d Histogram of all MET 
voxel values in the area selected with the FDG threshold method. 
The Y-axis represents the number of voxels, and the X-axis represents 
voxel value (SUV). The left peak (arrow) is the most frequent voxel 
value from MET-PET, i.e., the mode used in this study. The right 
peak mainly corresponds to tumour. e Representative slice of MET-
PET, on which the finally selected voxels are shown in red. Each red 
voxel is magnified by 9 (3 × 3) to facilitate visualization
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knowledge, this is the first proposal of an automated voxel-
based method to calculate normal grey matter values.
FDG-PET and MET-PET are widely used in evaluat-
ing brain tumour, but the methods that are used to calcu-
late metabolic indices are not consistent. Most previous 
studies have employed a ROI-based method for calculating 
the T/N ratio to evaluate brain tumour, but the procedure 
for localization of the normal cortex varies among studies. 
The standard method relies on careful placement of an ROI 
using visual inspection by an expert. However, this is not a 
fully objective method and inter-operator variability is una-
voidable. Although this variability can be avoided using a 
fixed ROI template [10, 15], the template method requires 
morphological normalization and is, therefore, difficult to 
apply to post-operative patient images. We believe that the 
new automated method we present in this report may over-
come these disadvantages.
Our method relies on two assumptions. First, it relies on 
the assumption that normal grey matter shows consistently 
high FDG uptake. The optimal FDG threshold determined 
by our method can thus extract a sufficient normal cortex 
region. The second assumption is that the area of brain 
tumour is not more than half the area of the brain. That is, 
within the area higher than the optimal FDG threshold, the 
voxels with the mode or the mean MET value are consid-
ered to correspond to the voxels showing normal cortex. 
This second step can exclude the tumour area if FDG-avid 
tumour is selected by the FDG-PET threshold method. If 
these assumptions are not held, such as a situation in which 
FDG uptake in a large area of grey matter was low due to 
impaired consciousness and the existence of a large FDG-
avid tumour, our method may not have succeeded.
Through an optimization step, we determined that the 
parameter combination of a threshold of 2.3 of FDG and 
the mode MET value resulted in optimum N-values. The 
mode MET value is a more reasonable parameter than 
the mean MET value, because the latter can be calculated 
from the voxel values of both normal cortex and tumour 
area if FDG-avid tumour is selected by the FDG thresh-
old method. Selection of the voxels of the mode MET 
value successfully excluded the tumour area, as shown in 
Fig. 3. In this study, median MET value was not included 
Fig. 4  Representative images and data from a patient in group 3. a, b 
Manually placed ROIs at the centrum semiovale level and at the stria-
tum level on FDG-PET (a) and MET-PET (b). Brain tumour is not 
distinctive on FDG-PET but can be somewhat visualized in the poste-
rior area of the resection cavity on MET-PET (arrows). c Representa-
tive slice of co-registered FDG-PET. The red area shows the candi-
date region for normal grey matter determined using the method. d 
Histogram of all MET voxel values from normal grey matter area 
selected by the FDG threshold method. The Y-axis represents the 
number of voxels, and the X-axis represents voxel value (SUV). The 
peak is the most frequent voxel values from MET-PET, i.e., the mode 
used in this study. e Representative slice of MET-PET, on which the 
finally selected voxels are shown in red. Each red voxel is magnified 
by 9 (3 × 3) to facilitate visualization
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as a parameter, because we believed that it was difficult to 
determine its clinical meaning or implications and, further-
more, it was less effective in excluding FDG-avid tumours. 
Nevertheless, we checked the result using the median MET 
value and found that ICC reached the maximum value at an 
FDG threshold of 2.3. Although the ICC was the maximum 
value at a threshold of 2.3, the ICC curve was gradual and 
close to 1.00 at a threshold ranging from 2.0 to 2.5. There-
fore, the threshold may vary around 2.3 depending on the 
learning data.
When we checked the selected voxels in detail, we 
observed that the rim of normal grey matter tended to be 
selected in the cases where FDG accumulation was rela-
tively high, and where FDG accumulation was relatively 
low, the peak area of the grey matter was selected instead. 
This phenomenon probably caused the proportional sys-
temic bias seen prominently in the FDG N-values using a 
Bland–Altman analysis. To determine whether this propor-
tional error is acceptable, we need further studies compar-
ing the automated method with the results of pathological 
Fig. 5  Scatter plots of FDG-PET N-values determined by the auto-
mated voxel-based method and those determined by each of three 
operators using the manual ROI. Group 2 consists of patients with 
primary glioma and group 3 consists of patients with recurrent brain 
tumour. The unit of the y-axes (N-value) is standardized uptake value
Fig. 6  Scatter plots of MET-PET N-values determined by the auto-
mated voxel-based method and those determined by each of three 
operators using the manual ROI method. Group 2 consists of patients 
with primary glioma and group 3 consists of patients with recurrent 
brain tumour. The unit of the y-axes (N-value) is standardized uptake 
value
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grading and clinical outcome. In this study, the manual 
method was considered to be the reference standard; how-
ever, this does not avoid operator bias. In the fully auto-
mated method, it will be helpful in reducing the time 
needed for the manual calculation and can provide a stand-
ard that can be used in multicenter studies.
Our new method was developed without a considera-
tion of any differences in MET distribution throughout 
the normal brain cortex. MET uptake has been reported to 
be relatively high in the occipital cortex, cerebellum, and 
thalamus [15, 16]. In our study, the N-value obtained from 
the normal reference region determined by our new method 
was strongly correlated with the results of a standard man-
ual method in which ROIs were placed on the frontal, pari-
etal, and temporal lobes. These regions do not include the 
areas of high MET uptake reported by the previous studies. 
Therefore, the development of our automated method was 
probably not affected by regional differences of normal cor-
tex MET uptake.
A major limitation of our method is the requirement 
for both FDG and MET-PET. FDG-PET has a role in 
identifying the candidate region of normal grey mat-
ter. Therefore, it may be replaced with MRI when co-
registration between MET-PET and MRI is successful 
using an automated method, and an optimal method of 
Table 1  Intraclass correlation coefficient (ICC) using a two-way 
random-effects model across N-values determined manually by each 




 FDG 3 operators 0.96 0.83–0.99
3 operators + automated method 0.96 0.87–0.99
 MET 3 operators 0.78 0.54–0.93
3 operators + automated method 0.78 0.56–0.92
Group 3
 FDG 3 operators 0.98 0.88–0.99
3 operators + automated method 0.98 0.94–0.99
 MET 3 operators 0.97 0.82–0.99
3 operators + automated method 0.96 0.89–0.99
Fig. 7  Scatter plots of the N-values determined by the automated voxel-based method and the mean manual N-values. The x- and y-axes both 
represent standardized uptake value. The reference dashed line represents the line-of-identity
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extracting normal grey matter from MRI images is vali-
dated. Co-registration can be successful using the mutual 
information method [17]. A PET-MR device may pre-
clude the need for co-registration processes [18]. Another 
limitation is the necessity to decide the threshold value 
of FDG-PET and to decide whether to use the mean or 
the mode of MET-PET voxel values. These parameters 
should be optimized using data sets obtained by the same 
PET protocol.
In conclusion, we have developed a new automated 
voxel-based method for calculating the N-value of the 
T/N ratio for the evaluation of brain tumour. Both high 
reliability and a strong correlation with the conventional 
manual ROI method were obtained in patients with pri-
mary brain tumour and in patients with recurrent tumour 
after surgery. This is the first automated voxel-based 
method for providing the N-value needed for calculating 
a metabolic index. Further investigation will be needed to 
validate our new method for wider use.
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